NEW YORK (GenomeWeb News) – Shareholders of UK-based Stem Cell Sciences have voted in favor of selling the firm's assets to Stem Cell Sciences.

The vote is the most recent step in SCS' plans to sell off its assets and delist from the AIM and Australian Securities Exchange.

The firms announced the nearly $5 million deal earlier this month.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.